In a petition filed with the FDA, Public Citizen is asking the agency to withdraw the Victoza diabetes treatment sold by Novo Nordisk due to increased risks that patients may developed pancreatitis, serious allergic reactions and kidney failure. And citing internal agency documents, the consumer watchdog notes that Victoza was approved in early 2010 against the advice of two FDA pharmacologists and an FDA clinical safety who reviewed pre-approval studies.
Well, it sounds logical that the meicine which is not sufficiently safe should be withdrawn... And the expected answer from Novo Nordisk should be: “OK, let's take it out from the market and try to develop something better.”
No way! It would be too simple for too complicated Big Pharma. The answer was following: Novo Nordisk says group's claims are groundless.
So we can see a conflict here. And we will follow how this conflict will be developed. Very interesting question: who is staying behind these Public Citizens (who is real counterpart of Novo Nordisk)?
No comments:
Post a Comment